However, there are also limitations of PbtO 2 monitoring that need to be considered. The catheter monitors a restricted area of brain tissue and the determinants of PbtO 2 are still debated and require further examination. Although the association between low PbtO 2 and poor outcome appears to be strong, it is much less certain whether PbtO 2 -directed therapy improves outcome. Lastly, while several studies of PbtO 2 monitoring in adult patients have been conducted, much less is known about PbtO 2 monitoring in children.
Technical Aspects of Brain Tissue Oxygen Monitoring
Three PbtO 2 devices have been produced commercially: Licox (Integra Neurosciences, Plainsboro, NJ), Neurotrend (Codman, Raynham, MA), and Neurovent-PTO (Raumedic, Münchberg, Germany). Of these, the Licox system is most widely used, and also measures brain temperature in the same catheter (IT2). The Neurotrend is no longer commercially available.
The Neurovent-PTO is novel in that it also measures ICP, but is new on the market and few data on its clinical reliability are currently available. The Licox system is based on a Clarke-type polargraphic cell containing two electrodes covered by a membrane. The amount of O 2 diffusing across this membrane depends on local tissue pO 2 and determines the electrical current between the two electrodes. 12 Several studies have confirmed the reliability of the PbtO 2 signal, in vitro accuracy, and low sensitivity and zero drift over time. 5, [14] [15] [16] [17] [18] The sampling area is approximately 14-17mm 3 .
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Normal and Abnormal Brain Tissue Oxygen Values
Normal values in humans are not precisely known. Because the PbtO 2 value is influenced strongly by local cerebral blood flow (CBF), the value varies widely depending on the metabolic activity and diffusion characteristics of the region being monitored. 22 However, variability is reduced during periods of ischemia. 21 74 and PbtO 2 decreases after hemorrhagic shock but responds to resuscitation. [75] [76] [77] Therefore, the avoidance of significant anemia in TBI is warranted. However, the thresholds for transfusion are unclear because transfusion has potential systemic adverse effects, transfused stored blood does not have the same oxygen-carrying capacity as the patient's blood, and the impact of the change in rheology in the microvasculature is uncertain. Blood transfusion has a variable influence on PbtO 2 , but prediction of the response based on pre-transfusion variables is elusive.
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Diffusion Barriers to Brain Tissue Oxygen
Oxygen transport in the tissues occurs by diffusion, which is affected by PaO 2 . 81 The diffusion distance between O 2 in the capillary and the cell is an important factor determining intracellular oxygen tension, so tissue oxygen decreases non-linearly in the extracellular space with increasing distance from the vessel. 82 Diffusion-limited tissue oxygenation in TBI may be as important as perfusion-limited ischemia, but is more difficult to diagnose. In TBI, microvascular factors that may increase the diffusion distance for oxygen include cytotoxic cell swelling, perivascular edema, collapsed capillaries, and arteriovenous shunting. 51 If these factors play a significant role in impairing oxygen diffusion to the cell, the partial pressure of oxygen in the capillary may be of greater significance than in normal physiology.
Brain Tissue Oxygen and Outcome in Adult Patients
Several studies have examined the relationship between PbtO 2 and outcome after TBI in adult patients. 17 However, there are few papers that have specifically examined PbtO 2 monitoring in children. 28, 94, 95 The evidence from these agrees with the adult studies that low PbtO 2 is associated with poor outcome. In particular, the longer patients had PbtO 2 below 20mmHg, the more likely they were to have a poor outcome, 28 with the key threshold of 10mmHg having the strongest association with outcome. 96 Markers of primary injury severity do not appear to predict which patients are at risk for secondary brain tissue hypoxic insults. 97 Importantly, significantly low PbtO 2 (<10mmHg) may occur in up to 30% of patients despite conventional treatment according to internationally accepted recommendations for the management of pediatric severe TBI. 28 In the largest of these pediatric studies (52 children with severe TBI), low PbtO 2 (<10mmHg) was independently associated with poor outcome (mortality and dichotomized outcome parameters using the Glasgow Outcome Score and Pediatric Cerebral Performance Category Score). In summary, studies in children suggest that episodes of low PbtO 2 are common in TBI, are not predicted by other conventional monitoring, and are associated with poor outcome. Although mortality in the largest series was low, and historical cohort studies in adults suggest benefit to patients, PbtO 2 -directed treatment has not been subjected to a randomized trial as yet.
A Practical Guide to Managing Low Brain Tissue Oxygen-An Institutional Approach
Placement of Catheters
At our institution, a PbtO 2 monitor is placed whenever we monitor ICP in patients with acute neurological pathology. The catheter is placed into 
Interpretation of Other Variables
In addition to the treatment of low PbtO 2 , we have found the response of 
